Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China flag China · Delayed Price · Currency is CNY
29.93
-0.56 (-1.84%)
Sep 2, 2026, 3:00 PM CST

SHA:603590 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
340.94332.57189.98230.2345.25599.08
Short-Term Investments
-136.3953.82183.820.7510.81
Trading Asset Securities
480.22500.43450.66396.41280.379.04
Cash & Short-Term Investments
821.15969.39694.46810.43626.36618.93
Cash Growth
-9.38%39.59%-14.31%29.39%1.20%-59.49%
Accounts Receivable
306.52278.09257.38282.83296.39244.38
Other Receivables
76.1876.0733.8435.5627.736.31
Receivables
382.7354.16291.22318.39324.13250.69
Inventory
56.4654.4772.3848.4736.9947.02
Other Current Assets
129.4717.5128.4852.6729.2331.19
Total Current Assets
1,3901,3961,0871,2301,017947.83
Property, Plant & Equipment
391.4404.15426.73414.54440.14407.06
Long-Term Investments
999.661,0781,249984.45927.15695.95
Goodwill
---97.6497.6497.64
Other Intangible Assets
828.77833.37842.67854.64812.75815.17
Long-Term Deferred Tax Assets
11.0721.3627.4732.271.098.96
Long-Term Deferred Charges
333.01308234.36150.71120.4582.41
Other Long-Term Assets
166.8854.9153.3116.68.87316.3
Total Assets
4,1214,0953,9203,7813,4253,371

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
20.4431.273.5782.9748.4746.74
Accrued Expenses
31.6558.2745.6832.1526.8233.99
Short-Term Debt
314.44253.45140.9696.93--
Current Portion of Long-Term Debt
36.662.641.075.12--
Current Portion of Leases
-6.6173.958.717.5
Current Income Taxes Payable
13.360.714.690.2534.1215.84
Current Unearned Revenue
2.1855.956.436.492.921.2
Other Current Liabilities
126.1650.6273.2995.5351.3249.49
Total Current Liabilities
544.9459.45352.68323.39172.36154.77
Long-Term Debt
25.5954.2849.8543.78--
Long-Term Leases
0.23.1710.8-3.7111.12
Long-Term Unearned Revenue
39.3141.8740.4823.4928.9829.83
Long-Term Deferred Tax Liabilities
35.9239.7439.7227.7829.6245.02
Total Liabilities
645.92598.51493.52418.44234.68240.74

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
159.01159.01159.36160160160
Additional Paid-In Capital
950.7948.77944.6955.01992.46985.17
Retained Earnings
2,1562,1152,0452,0501,9311,876
Treasury Stock
-78.66-32.86-35.93-78.59-124.64-124.64
Comprehensive Income & Other
-2.4421.1431.8-26.5-32.8-8.11
Total Common Equity
3,1853,2113,1443,0602,9262,889
Minority Interest
290.05285.21281.75302.44264.22241.81
Shareholders' Equity
3,4753,4963,4263,3623,1903,131
Total Liabilities & Equity
4,1214,0953,9203,7813,4253,371

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
376.9320.16209.67149.7812.4218.62
Net Cash (Debt)
444.25649.23484.79660.65613.94600.31
Net Cash Growth
-31.92%33.92%-26.62%7.61%2.27%-60.08%
Net Cash Per Share
2.784.073.104.223.933.81
Filing Date Shares Outstanding
156.47157.53159.22158.98156.49156.49
Total Common Shares Outstanding
156.47158.61158.83158.98156.49156.49
Working Capital
844.89936.08733.86906.57844.35793.06
Book Value Per Share
20.3520.2519.8019.2518.7018.46
Tangible Book Value
2,3562,3782,3022,1082,0161,976
Tangible Book Value Per Share
15.0614.9914.4913.2612.8812.63
Buildings
-404.81324.61322.64323.38322.3
Machinery
-181.48126.83125.74126.76114.72
Construction In Progress
-81.73209.85190.8181.98127.26